Claudio Pietra

3.3k total citations · 1 hit paper
79 papers, 2.8k citations indexed

About

Claudio Pietra is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Claudio Pietra has authored 79 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 25 papers in Physiology. Recurrent topics in Claudio Pietra's work include Regulation of Appetite and Obesity (19 papers), Neuropeptides and Animal Physiology (16 papers) and Urinary Bladder and Prostate Research (14 papers). Claudio Pietra is often cited by papers focused on Regulation of Appetite and Obesity (19 papers), Neuropeptides and Animal Physiology (16 papers) and Urinary Bladder and Prostate Research (14 papers). Claudio Pietra collaborates with scholars based in Italy, United States and Japan. Claudio Pietra's co-authors include Stefan Catsicas, Marc Missotten, Michel Dubois‐Dauphin, Dominique Talabot, Iván Rodríguez, Jean‐Claude Martinou, Harald Frankowski, Julie K. Staple, David G. Trist and Stéfano Palea and has published in prestigious journals such as Neuron, Gastroenterology and Advanced Drug Delivery Reviews.

In The Last Decade

Claudio Pietra

79 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overexpression of BCL-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia

1994 934 citations Claudio Pietra et al. profile →

Peers

Claudio Pietra

CMN

PHYSI

UROLO

EAS

Maria Giuliana Vannucchi Italy

Thomas J. Heppner United States

Dana S. Hutchinson Australia

Kunio Ishii Japan

Hikaru Suzuki Japan

Neil J. Hayward United States

Silvia Giatti Italy

Ana Patricia Fernández Spain

Pedro J. Camello Spain

D P Westfall United States

Maria Giuliana Vannucchi Italy

Claudio Pietra

846 ×0.7

619 ×0.8

CMN

747 ×1.1

PHYSI

146 ×0.4

UROLO

215 ×0.6

EAS

Citations per year, relative to Claudio Pietra Claudio Pietra (= 1×) peers Maria Giuliana Vannucchi

Countries citing papers authored by Claudio Pietra

Since Specialization

Citations

This map shows the geographic impact of Claudio Pietra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Pietra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Pietra more than expected).

Fields of papers citing papers by Claudio Pietra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Pietra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Pietra. The network helps show where Claudio Pietra may publish in the future.

Co-authorship network of co-authors of Claudio Pietra

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Pietra. A scholar is included among the top collaborators of Claudio Pietra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Pietra. Claudio Pietra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ruzza, Chiara, Federica Ferrari, P. Pola, et al.. (2024). In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays. European Journal of Pharmacology. 981. 176880–176880. 1 indexed citations

Mensah, Afua A., Filippo Spriano, Giulio Sartori, et al.. (2021). Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors. Blood Advances. 5(10). 2467–2480. 12 indexed citations

Chruścicka, Barbara, Daniela Felice, Claudio Pietra, et al.. (2020). Behavioural characterization of ghrelin ligands, anamorelin and HM01: Appetite and reward-motivated effects in rodents. Neuropharmacology. 168. 108011–108011. 8 indexed citations

Mayo, Bronwen J., Kate R. Secombe, Anthony Wignall, et al.. (2020). The GLP-2 analogue elsiglutide reduces diarrhoea caused by the tyrosine kinase inhibitor lapatinib in rats. Cancer Chemotherapy and Pharmacology. 85(4). 793–803. 20 indexed citations

Louwies, Tijs, et al.. (2020). <p>Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics</p>. Journal of Experimental Pharmacology. Volume 12. 267–274. 3 indexed citations

Rodriguez, Juan A., Emily C. Bruggeman, Bharath K. Mani, et al.. (2018). Ghrelin Receptor Agonist Rescues Excess Neonatal Mortality in a Prader-Willi Syndrome Mouse Model. Endocrinology. 159(12). 4006–4022. 21 indexed citations

Chiorazzi, A, Krystyna M. Wozniak, Rana Rais, et al.. (2018). Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models. European Journal of Pharmacology. 840. 89–103. 13 indexed citations

Palea, Stéfano, et al.. (2016). Netupitant, a Potent and Highly Selective NK1 Receptor Antagonist, Alleviates Acetic Acid-Induced Bladder Overactivity in Anesthetized Guinea-Pigs. Frontiers in Pharmacology. 7. 234–234. 5 indexed citations

Ruzza, Chiara, Anna Rizzi, Davide Malfacini, et al.. (2015). In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant. Peptides. 69. 26–32. 7 indexed citations

10.

Mayo, Bronwen J., Emma Bateman, Andrea M. Stringer, et al.. (2014). The new selective glp-2 receptor agonist, elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the rat. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 3 indexed citations

11.

Mayo, Bronwen J., Andrea M. Stringer, Emma Bateman, et al.. (2014). Apoptosis, proliferation and inflammation are improved after treatment with the new selective glp-2 receptor agonist, elsiglutide, in a rat model of irinotecan-induced mucositis. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 1 indexed citations

12.

Meerveld, Beverley Greenwood–Van, et al.. (2014). Synergistic Effect of 5-Hydroxytryptamine 3 and Neurokinin 1 Receptor Antagonism in Rodent Models of Somatic and Visceral Pain. Journal of Pharmacology and Experimental Therapeutics. 351(1). 146–152. 18 indexed citations

13.

Pintér, Erika, Anikó Perkecz, Ágnes Kemény, et al.. (2014). Role of neurokinin 1 receptors in dextran sulfate-induced colitis: studies with gene-deleted mice and the selective receptor antagonist netupitant. Inflammation Research. 63(5). 399–409. 12 indexed citations

14.

Palea, Stéfano, et al.. (2010). Comparison of the effects of netupitant and tolterodine on overactive bladder induced by intravesical acetic acid infusion in anesthetized female guinea-pigs.. Neurourology and Urodynamics. 2 indexed citations

15.

Rojas, Camilo, Ying Li, Jie Zhang, et al.. (2010). The Antiemetic 5-HT3 Receptor Antagonist Palonosetron Inhibits Substance P-Mediated Responses In Vitro and In Vivo. Journal of Pharmacology and Experimental Therapeutics. 335(2). 362–368. 108 indexed citations

16.

Villetti, Gino, M. A. C. M. Bergamaschi, Pier Tonino Bolzoni, et al.. (2003). Antinociceptive Activity of the N-Methyl-d-aspartate Receptor Antagonist N-(2-Indanyl)-glycinamide Hydrochloride (CHF3381) in Experimental Models of Inflammatory and Neuropathic Pain. Journal of Pharmacology and Experimental Therapeutics. 306(2). 804–814. 66 indexed citations

17.

Redenti, Enrico, Claudio Pietra, A. Gerlóczy, & Lajos Szente. (2001). Cyclodextrins in oligonucleotide delivery. Advanced Drug Delivery Reviews. 53(2). 235–244. 53 indexed citations

18.

Trabace, Luigia, Addolorata Maria Luce Coluccia, Silvana Gaetani, et al.. (2000). In vivo neurochemical effects of the acetylcholinesterase inhibitor ENA713 in rat hippocampus. Brain Research. 865(2). 268–271. 18 indexed citations

19.

Crespi, Francesco & Claudio Pietra. (1997). Middle cerebral artery occlusion alters neurotransmitter activities in ipsilateral and contralateral rat brain regions: an ex vivo voltammetric study. Neuroscience Letters. 230(2). 77–80. 16 indexed citations

20.

Peng, Zechun, Claudio Pietra, Andrea Sbarbati, et al.. (1996). Induction of NADPH-diaphorase Activity in the Rat Forebrain after Middle Cerebral Artery Occlusion. Experimental Neurology. 138(1). 105–120. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact